GlobalData Plc: AstraZeneca a Key Player in the Small Cell Lung Cancer Drugs Market LONDON, May 31, 2022 (GLOBE NEWSWIRE) -- SCLC is marked by an exceptionally high proliferative rate, a strong predilection for early metastasis, and a poor prognosis. Most patients have metastatic...